211 related articles for article (PubMed ID: 35167594)
1. Host tissue proteomics reveal insights into the molecular basis of Schistosoma haematobium-induced bladder pathology.
Osakunor DNM; Ishida K; Lamanna OK; Rossi M; Dwomoh L; Hsieh MH
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010176. PubMed ID: 35167594
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.
Ray D; Nelson TA; Fu CL; Patel S; Gong DN; Odegaard JI; Hsieh MH
PLoS Negl Trop Dis; 2012; 6(11):e1912. PubMed ID: 23209855
[TBL] [Abstract][Full Text] [Related]
3. A novel mouse model of Schistosoma haematobium egg-induced immunopathology.
Fu CL; Odegaard JI; Herbert DR; Hsieh MH
PLoS Pathog; 2012; 8(3):e1002605. PubMed ID: 22479181
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 are modulated by host sex.
Honeycutt J; Hammam O; Hsieh MH
Exp Parasitol; 2015 Nov; 158():55-60. PubMed ID: 26160678
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma haematobium cercarial infection alters subsequent systemic immune responses to eggs but has minimal impact on immune responses to egg injection of the bladder.
Loc L; Mbanefo EC; Khludenev G; Lamanna O; Banskota N; Hsieh MH
Parasite Immunol; 2019 Jan; 41(1):e12602. PubMed ID: 30417508
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 Signaling Plays a Major Role in Urogenital Schistosomiasis-Associated Bladder Pathogenesis.
Mbanefo EC; Fu CL; Ho CP; Le L; Ishida K; Hammam O; Hsieh MH
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31843965
[TBL] [Abstract][Full Text] [Related]
7. Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.
Honeycutt J; Hammam O; Fu CL; Hsieh MH
Trends Parasitol; 2014 Jul; 30(7):324-32. PubMed ID: 24913983
[TBL] [Abstract][Full Text] [Related]
8. H-IPSE Is a Pathogen-Secreted Host Nucleus-Infiltrating Protein (Infiltrin) Expressed Exclusively by the Schistosoma haematobium Egg Stage.
Pennington LF; Alouffi A; Mbanefo EC; Ray D; Heery DM; Jardetzky TS; Hsieh MH; Falcone FH
Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28923894
[TBL] [Abstract][Full Text] [Related]
9. IPSE, a urogenital parasite-derived immunomodulatory molecule, suppresses bladder pathogenesis and anti-microbial peptide gene expression in bacterial urinary tract infection.
Mbanefo EC; Le L; Pennington LF; Hsieh YJ; Odegaard JI; Lapira K; Jardetzky TS; Falcone FH; Hsieh MH
Parasit Vectors; 2020 Dec; 13(1):615. PubMed ID: 33298153
[TBL] [Abstract][Full Text] [Related]
10. The host-parasite relationship of Schistosoma haematobium in CBA mice.
Agnew AM; Lucas SB; Doenhoff MJ
Parasitology; 1988 Dec; 97 ( Pt 3)():403-24. PubMed ID: 3146052
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling for biomarkers in Schistosoma haematobium infection and associated bladder pathologies.
Adebayo AS; Mundhe SD; Awobode HO; Onile OS; Agunloye AM; Isokpehi RD; Shouche YS; Santhakumari B; Anumudu CI
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006452. PubMed ID: 29708967
[TBL] [Abstract][Full Text] [Related]
12. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
[TBL] [Abstract][Full Text] [Related]
13. Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.
Bernardo C; Cunha MC; Santos JH; da Costa JM; Brindley PJ; Lopes C; Amado F; Ferreira R; Vitorino R; Santos LL
Tumour Biol; 2016 Aug; 37(8):11279-87. PubMed ID: 26951512
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity.
Reimert CM; Mshinda HM; Hatz CF; Kombe Y; Nkulila T; Poulsen LK; Christensen NO; Vennervald BJ
Am J Trop Med Hyg; 2000 Jan; 62(1):19-28. PubMed ID: 10761720
[TBL] [Abstract][Full Text] [Related]
15. Development of Urinary Bladder Pre-Neoplasia by
Chala B; Choi MH; Moon KC; Kim HS; Kwak C; Hong ST
Korean J Parasitol; 2017 Feb; 55(1):21-29. PubMed ID: 28285503
[No Abstract] [Full Text] [Related]
16. A new mouse model for female genital schistosomiasis.
Richardson ML; Fu CL; Pennington LF; Honeycutt JD; Odegaard JI; Hsieh YJ; Hammam O; Conti SL; Hsieh MH
PLoS Negl Trop Dis; 2014 May; 8(5):e2825. PubMed ID: 24786606
[TBL] [Abstract][Full Text] [Related]
17. T-helper 17 cells are associated with pathology in human schistosomiasis.
Mbow M; Larkin BM; Meurs L; Wammes LJ; de Jong SE; Labuda LA; Camara M; Smits HH; Polman K; Dieye TN; Mboup S; Stadecker MJ; Yazdanbakhsh M
J Infect Dis; 2013 Jan; 207(1):186-95. PubMed ID: 23087431
[TBL] [Abstract][Full Text] [Related]
18. The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer.
Vale N; Gouveia MJ; Rinaldi G; Santos J; Santos LL; Brindley PJ; da Costa JM
Tumour Biol; 2017 Mar; 39(3):1010428317692247. PubMed ID: 28345469
[TBL] [Abstract][Full Text] [Related]
19. Macrophages are required for host survival in experimental urogenital schistosomiasis.
Fu CL; Odegaard JI; Hsieh MH
FASEB J; 2015 Jan; 29(1):193-207. PubMed ID: 25351984
[TBL] [Abstract][Full Text] [Related]
20. In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
Sotillo J; Pearson MS; Becker L; Mekonnen GG; Amoah AS; van Dam G; Corstjens PLAM; Murray J; Mduluza T; Mutapi F; Loukas A
PLoS Negl Trop Dis; 2019 May; 13(5):e0007362. PubMed ID: 31091291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
